Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic

Antoine M Snijders1, Yueyong Liu1,2, Li Su1

  • 1Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.

Oncotarget
|November 18, 2015
PubMed

Insights

The tumor suppressor FBXW7 (F-box and leucine-rich repeat protein with WD40 repeats 7) gene impacts cancer development. Its gene signatures in mouse models predict patient survival, offering potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The FBXW7 gene is a crucial tumor suppressor, frequently altered in human cancers.
  • FBXW7 regulates oncoproteins like mTOR through ubiquitination, impacting cell growth and survival.
  • Understanding FBXW7's role is vital for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the role of FBXW7 in tumor development using gene transcript profiling.
  • To assess the impact of mTOR inhibition by rapamycin on tumor gene expression and biological functions.
  • To identify conserved FBXW7 gene signatures between mouse models and human cancers.

Main Methods:

  • Gene transcript profiling of radiation-induced thymic lymphomas in Fbxw7/p53 double heterozygous mice.
  • Comparison of gene expression in tumors with and without rapamycin treatment.
  • Analysis of conserved gene signatures and their correlation with patient survival data.

Main Results:

  • Fbxw7/p53 heterozygous tumors showed deregulation of cholesterol metabolism, independent of rapamycin.
  • Cell cycle genes were upregulated in placebo-treated tumors but not in rapamycin-treated tumors.
  • Rapamycin treatment enriched for integrated stress response genes in Fbxw7/p53 heterozygous tumors.
  • FBXW7 gene signatures in mouse tumors significantly overlapped with human cancers and predicted disease-free survival.

Conclusions:

  • FBXW7 plays a significant role in tumor development, influencing metabolic and cell cycle pathways.
  • mTOR inhibition by rapamycin modulates the tumor transcriptome, impacting stress response.
  • Conserved FBXW7 gene signatures offer predictive biomarkers for patient survival and potential therapeutic targets in various cancers.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K